The National Academies will host a workshop on "Public-Private Partnerships for Data-Informed Decision-Making to Distribute, Dispense, and Administer Medical Countermeasures" on October 3, 2023. Lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). However, less

The National Academies will host a workshop on “Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures” on 12 October 2023. Lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). However, less attention was given

The National Academies will host a workshop on “Public-Private Partnerships for Dispensing and Administration of Medical Countermeasures” on 17 October 2023. Lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). However, less attention was given

The National Academies will host a workshop on “Public-Private Partnerships for Distribution of Medical Countermeasuress” on 26 October 2023. Lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical countermeasures). However, less attention was given to public-private

The National Academies will host a workshop on “Future Opportunities: Levers and Systems for Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures” on 2 November 2023. Lessons learned from past health emergencies highlight the importance of public-private partnerships to facilitate and accelerate the research, development, and manufacturing of vaccines, therapeutics, and diagnostics (i.e., medical

The National Academies will host a webinar on November 6 on Charting a Responsible Future in AI & Biosecurity. Organized by the Health and Medicine Division’s Forum on Microbial Threats and the Division of Earth and Life Studies’ Board on Life Sciences, this is the first of two sessions bringing together technology developers, researchers, and